A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2004
11/03/2004	EP1289514B1 Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
11/03/2004	EP1286957B1 Diphenylmethane derivatives
11/03/2004	EP1278547B1 Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
11/03/2004	EP1267892B1 Use of cdp-choline for the treatment of alcohol withdrawal syndrome
11/03/2004	EP1261609B1 Triazolotriazinones and the use thereof
11/03/2004	EP1250331B1 Formulation for protection against oxidative stress containing benzofuranone derivatives
11/03/2004	EP1235814B1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS
11/03/2004	EP1232153B1 Imidazole derivatives and their use as raf kinase inhibitors
11/03/2004	EP1207907B1 Compositions for treating viral infections, and methods therefor
11/03/2004	EP1207884B1 Use of cgrp antagonists and cgrp release inhibitors for controlling menopausal hot flashes
11/03/2004	EP1206452B1 Novel method for preparing benzoperhydroisoindole compounds
11/03/2004	EP1206257B1 Use of amino acids for making medicines for treating insulin-resistance
11/03/2004	EP1189883B1 Substituted pyrrolidines as cell adhesion inhibitors
11/03/2004	EP1173177B1 Use of macrolide compounds for the treatment of dry eye
11/03/2004	EP1121929B1 Composition comprising di- and trisodiumsalts of echinochrome for treating ocular conditions
11/03/2004	EP1112742B1 Remedies or preventives containing cyclopentenone compounds as the active ingredient
11/03/2004	EP1105371B1 Novel aryl sulphonamide amino acid esters and analogues
11/03/2004	EP1102586B1 Use of ginkgo biloba extracts for preparing a medicine for treating amyotrophic lateral sclerosis
11/03/2004	EP1083899A4 Method of enhancing lysosomal alpha-galactosidase a
11/03/2004	EP1071464B1 Spray-dried powders with high edible-oil loadings based on non-hydrolyzed gelatin and a method of making such spray-dried tablettable powders
11/03/2004	EP1003554B1 Proton pump inhibitor in therapeutic combination with antibacterial substances
11/03/2004	EP0993446B1 Process for preparing nifedipine
11/03/2004	EP0989850B1 Use of pramipexole in the treatment of restless legs syndrome
11/03/2004	EP0971686B1 Cosmetic and/or dermatological composition containing a derivative of methylated silanol and a derivative of hydrolysed plant protein
11/03/2004	EP0956021B1 L-beta-dioxolane uridine analogs for treating and preventing infections by ebv, vzv and hv-8
11/03/2004	EP0942906B1 Compounds useful for inhibition of farnesyl protein transferase
11/03/2004	EP0923376B1 Use of steroids for treatment of asthma and airway diseases
11/03/2004	EP0907360B1 Method for maintaining an existing level of body fat and/or body weight
11/03/2004	EP0896625B1 Recombinant ribonuclease proteins
11/03/2004	EP0888118B1 Enhancement of microbial colonisation of the gastrointestinal tract
11/03/2004	EP0877748B1 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use
11/03/2004	EP0798292B1 Aniline derivatives having nitrogen monoxide synthase inhibitory activity
11/03/2004	EP0788305B1 Composition for inactivating irritants in fluids
11/03/2004	EP0786994B1 Use of chloride channel blockers for reducing intraocular pressure
11/03/2004	EP0729325B1 Osteogenic product and use
11/03/2004	EP0722324B1 Pharmaceutical composition for immunoenhancement therapy
11/03/2004	CN1543570A Identifying compounds that modulate interaction of neuronal nitric oxide synthase and its inhibitor, useful e.g. for treating prediabetic states
11/03/2004	CN1543475A Novel genetic products from ashbya gossypii, associated withthe structure of the cell wall or the cytoskeleton
11/03/2004	CN1543473A Steroid compounds, use of these compounds for the preparation of meiosis-regulating medicaments and method for the preparation of these compounds
11/03/2004	CN1543472A 6-o-carbamoyl ketolide antibacterials
11/03/2004	CN1543468A Processes for preparing calcium salt forms of statins
11/03/2004	CN1543467A Diazacycloalkanes as oxytocin agonists
11/03/2004	CN1543466A New use of specific cyclolignans
11/03/2004	CN1543465A Novel heterocyclic compounds as selective bacterial DHFR inhibitors and their uses thereof
11/03/2004	CN1543464A Novel imidazopyridine compounds with therapeutic effect
11/03/2004	CN1543462A Crystals including a malic acid salt of a 3-pyrrole substituted 2-indolinone, and compositions thereof
11/03/2004	CN1543461A Melanocortin receptor ligands
11/03/2004	CN1543459A Quinoline derivatives and quinazoline derivatives having azolyl group
11/03/2004	CN1543456A Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
11/03/2004	CN1543453A 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
11/03/2004	CN1543451A Receptor modulators activated by peroxizonal proliferators (ppar)
11/03/2004	CN1543362A Medical products comprising a haemocompatible coating, production and use thereof
11/03/2004	CN1543359A Compositions and preparation methods for bioavailable oral aceclofenac dosage forms
11/03/2004	CN1543358A Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity
11/03/2004	CN1543357A 5-CNAC as oral delivery agent for parathyroid hormone fragments
11/03/2004	CN1543352A Method and material for treating immune diseases
11/03/2004	CN1543351A Method for enhancing the effectiveness of cancer therapies
11/03/2004	CN1543349A Enhanced drug delivery in transdermal systems
11/03/2004	CN1543348A Hypotensive lipid and timolol compositions and methods of using same
11/03/2004	CN1543347A Use of BIBN4096 in combination with other antimigraine drugs for the treatment of migraine
11/03/2004	CN1543346A Novel compounds
11/03/2004	CN1543345A Methods for selective immunomodulation using pimecrolimus
11/03/2004	CN1543344A Aryl(or hetero aryl) aza cyclopentadienyl carbinol ramifications for treating urinary incontinence
11/03/2004	CN1543343A Preparation and diabetic use of gibberellins
11/03/2004	CN1543342A Controlled heat induced rapid delivery of pharmaceuticals from skin depot
11/03/2004	CN1543341A Stabilization of solid thyroid drug formulations
11/03/2004	CN1543338A Chitin microparticles and their medical uses
11/03/2004	CN1543337A Expandable gastric retention device
11/03/2004	CN1542136A Method for production of cytosporasp B and the use in preparation of anti-tumor and antifungal medicine
11/03/2004	CN1542021A Sodium alginate sulfuric ester and preparation method and use thereof
11/03/2004	CN1542012A Cefetamet sodium and its application of preparing powder injection or dry powder injection for broad-spectrum strong antibiotic injection
11/03/2004	CN1542011A Sulphur containing heterocyclic and naphthalimides compound and use thereof
11/03/2004	CN1542010A Azolo triazines and pyrimidines
11/03/2004	CN1542009A Preparation method and use of dipyridanmole derivative
11/03/2004	CN1542006A Salt of phenylacetyl-(N-methyl)leucine-aspartic acid- phenylalanine-(N-methyl)piperazine
11/03/2004	CN1542005A Preparation method and use of sulfalene oxazole derivative
11/03/2004	CN1542004A Tyrosine kinase inhibitor, preparation method and use thereof
11/03/2004	CN1542003A Preparation method and use of trimethoprim derivative
11/03/2004	CN1542002A Inhibitors of metalloproteinase, pharmaceutical compositions containing them, their pharmaceutical application and methods and intermediate compounds for their preparation
11/03/2004	CN1542001A Small molecule inhibitors of rotamase enzyme activity
11/03/2004	CN1541711A Regulation of immune responses by manipulation of intermediary metabolite levels
11/03/2004	CN1541708A Use of insulin promoting peptide and nutrient, parenteral nutrition composition and pharmaceuticals
11/03/2004	CN1541706A Inhibitor and stimulator of stem cell proliferation and uses thereof
11/03/2004	CN1541653A Kudzu vine capsule for regulating blood pressure and blood fat, its preparation process
11/03/2004	CN1541652A Traditional Chinese medicine for treating upper respiratory tract infection and its preparation method
11/03/2004	CN1541651A Unit dosage glycyrrhizicacid diammonium freeze-dry powder injection formulation and its preparation method
11/03/2004	CN1541650A Chronic bronchitis treating traditional Chinese medicine
11/03/2004	CN1541649A Vincristine sulfate liposome drug and its preparation process
11/03/2004	CN1541648A Sodium bisulfate andrographolide aseptic powder for injection and its preparation method
11/03/2004	CN1541647A Di-acetyl-aminoethyl-ethylenediamine powder injection and its preparation method
11/03/2004	CN1541646A Hydroxyl methionine salt trace element additive preparation method
11/03/2004	CN1541645A Brufen derivative production method and uses
11/03/2004	CN1541644A Fluoxetine enteric coated tablet
11/03/2004	CN1541643A Use of Wangzaozi secondary element as immunological inhibitors
11/03/2004	CN1174097C Macrophage activating factors derived from cloned vitamin D binding protein
11/03/2004	CN1174037C Gel composition
11/03/2004	CN1173996C Atractylodes polyose with antineoplastic and immunoregualting functions and its preparing process and application
11/03/2004	CN1173991C Fik-1 as receiptor of growth factor of blood vessel inner-skin
11/03/2004	CN1173988C Resticidal macrolides
11/03/2004	CN1173979C Propenyl cephalosporin derivatives

1 ... 4906 4907 4908 4909 4910 4911 4912 4913 4914 4915 4916 4917 4918 4919 4920 4921 4922 4923 4924 4925 4926 ... 7860